Table 2. Clinical characteristics of women diagnosed with cancer in EMM, SA, 2017‒2020.
| Characteristics | Controls (n (%)) N = 851 |
Cases (n (%)) N = 2,217 |
p-value |
|---|---|---|---|
| HIV status | |||
| Negative | 70 (8.2) | 352 (15.9) | <0.001 |
| Positive | 90 (10.6) | 206 (9.3) | |
| Undisclosed | 691 (81.2) | 1,659 (74.8) | |
| Cancer stage at diagnosis | |||
| Stage I | 59 (6.9) | 118 (5.3) | <0.001 |
| Stage II | 57 (6.7) | 329 (14.8) | |
| Stage III | 34 (4.0) | 165 (7.4) | |
| Stage IV | 17 (2.0) | 31 (1.4) | |
| Unknown | 684 (80.4) | 1,574 (71.0) | |
| Basis of diagnosis | |||
| Autopsy | 2 (0.2) | 1 (<1) | <0.001 |
| Clinical | 55 (6.5) | 62 (2.8) | |
| Cytology (Fine needle aspiration) | 22 (2.6) | 45 (2.0) | |
| Death certificate only | 2 (0.2) | 11 (0.5) | |
| Histology | 762 (89.5) | 2,092 (94.4) | |
| Unknown | 8 (0.9) | 6 (0.3) | |